重新审视支气管肺发育不良的定义:早产儿呼吸支持方式变化的影响
该回顾性队列研究纳入加拿大新生儿网络2010至2011年出生、胎龄小于29周的早产儿,评估不同支气管肺发育不良定义对18至21月龄呼吸及神经发育结局的预测能力,发现仅用氧依赖不如氧/呼吸支持标准,且矫正胎龄40周时氧/呼吸支持对严重呼吸疾病预测最佳。
要点
- 仅以氧依赖定义支气管肺发育不良的预测能力低于氧/呼吸支持标准。
- 矫正胎龄36周时氧/呼吸支持标准对所有结局的预测AOR和AUC最高。
- 矫正胎龄40周时氧/呼吸支持对严重呼吸疾病预测最佳(AOR 6.1,95%CI 3.4-11.0)。
核心结论
- 仅用氧依赖定义支气管肺发育不良不充分,氧/呼吸支持是慢性呼吸功能不全的更好指标。
- 矫正胎龄40周时氧/呼吸支持是严重呼吸疾病的最佳预测指标,对18至21月龄神经感觉障碍也有良好预测能力。
研究设计与样本
- 回顾性队列研究,纳入加拿大新生儿网络参与中心2010至2011年出生、胎龄小于29周且完成18至21月龄随访的早产儿。
- 共1914例合格存活儿中1503例完成评估,平均胎龄26.3周,68%为白人,9%为黑人,23%为其他种族/族裔。
主要发现
- 1503例中88例发生严重呼吸疾病,257例存在神经感觉障碍,12例出院后死亡。
- 仅用氧依赖标准在各矫正胎龄的预测能力均低于氧/呼吸支持标准。
- 矫正胎龄36周时氧/呼吸支持标准对所有结局的AOR和AUC最高。
- 矫正胎龄34至44周间,氧/呼吸支持对严重呼吸疾病的预测能力从34周(AOR 1.8,95%CI 0.9-3.4,AUC 0.721)升至40周(AOR 6.1,95%CI 3.4-11.0,AUC 0.799)。
- 对严重神经感觉障碍,矫正胎龄40周时AOR 1.5(95%CI 1.0-2.1)、AUC 0.740,仅略低于37周峰值(AOR 1.8,95%CI 1.3-2.6,AUC 0.743)。
关键数值与推荐
- 氧/呼吸支持定义为接受补充氧和/或正压呼吸支持。
- 矫正胎龄36周时氧/呼吸支持标准对所有结局的AOR和AUC最高。
- 矫正胎龄40周时氧/呼吸支持对严重呼吸疾病AOR 6.1(95%CI 3.4-11.0),AUC 0.799。
临床怎么用
- 临床定义支气管肺发育不良时应纳入氧/呼吸支持而非仅氧依赖。
- 矫正胎龄40周时氧/呼吸支持状态可用于预测严重呼吸疾病及神经感觉障碍风险。
局限性
- 回顾性队列设计。
- 仅纳入加拿大新生儿网络中心,外推性受限。
- 出院后死亡例数少(12例),可能影响复合结局分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Several definitions of bronchopulmonary dysplasia are clinically used; however, their validity remains uncertain considering ongoing changes in the panoply of respiratory support treatment strategies used within neonatal units. OBJECTIVE: To identify the optimal definition of bronchopulmonary dysplasia that best predicts respiratory and neurodevelopmental outcomes in preterm infants. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at tertiary neonatal intensive care units. Preterm infants born at less than 29 weeks' gestation between 2010 and 2011 who were admitted to neonatal intensive care units participating in the Canadian Neonatal Network and completed follow-up assessments in a Canadian Neonatal Follow-Up Network clinic at 18 to 21 months. EXPOSURES: Various traditional bronchopulmonary dysplasia criteria based on respiratory status at different postmenstrual ages. MAIN OUTCOMES AND MEASURES: Serious respiratory morbidity, neurosensory impairment at 18 to 21 months of age, and a composite outcome of respiratory or neurosensory morbidity or death after discharge. Adjusted odds ratios (AORs) and 95% CIs were calculated. RESULTS: Of 1914 eligible survivors, 1503 were assessed (mean gestational age was 26.3 weeks; 68% were white, 9% were black, and 23% were other race/ethnicity), 88 had serious respiratory morbidity, 257 infants had neurosensory impairment, and 12 infants died after discharge. Definitions using oxygen requirement alone as the criterion at various postmenstrual ages were less predictive compared with those using the criterion of oxygen/respiratory support (RS) (receiving supplemental oxygen and/or positive-pressure RS); among those, oxygen/RS at 36 weeks had the highest AOR and area under the curve (AUC) for all outcomes. Further analyses of oxygen/RS at each week between 34 and 44 weeks' postmenstrual age indicated that the predictive ability for serious respiratory morbidity increased from 34 weeks (AOR, 1.8; 95% CI, 0.9-3.4, AUC, 0.721) to 40 weeks (AOR, 6.1; 95% CI, 3.4-11.0; AUC, 0.799). For serious neurosensory impairment, the AOR and AUC at 40 weeks' PMA (AOR, 1.5, 95% CI, 1.0-2.1; AUC, 0.740) were only marginally below their peak values at 37 weeks' PMA (AOR, 1.8; 95% CI, 1.3-2.6; AUC, 0.743). CONCLUSIONS AND RELEVANCE: Defining bronchopulmonary dysplasia by the use of oxygen alone is inadequate because oxygen/RS is a better indicator of chronic respiratory insufficiency. In particular, oxygen/RS at 40 weeks' PMA was identified as the best predictor for serious respiratory morbidity, while it also displayed a good ability to predict neurosensory morbidity at 18 to 21 months.
引用
- Isayama T, Lee SK, Yang J, et al. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates. JAMA Pediatr. 2017. PMID: 28114678. doi:10.1001/jamapediatrics.2016.4141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。